MX2018004282A - Nuevos procedimientos de fabricacion de barusiban y sus intermedios. - Google Patents
Nuevos procedimientos de fabricacion de barusiban y sus intermedios.Info
- Publication number
- MX2018004282A MX2018004282A MX2018004282A MX2018004282A MX2018004282A MX 2018004282 A MX2018004282 A MX 2018004282A MX 2018004282 A MX2018004282 A MX 2018004282A MX 2018004282 A MX2018004282 A MX 2018004282A MX 2018004282 A MX2018004282 A MX 2018004282A
- Authority
- MX
- Mexico
- Prior art keywords
- barusiban
- intermediates
- making
- new methods
- specifically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
Abstract
La presente invención se refiere a nuevos procedimientos de péptidos en fase sólida de síntesis de análogos que presentan actividad antagonista de oxitocina, específicamente barusiban y sus intermedios. Específicamente, la presente invención se refiere a un procedimiento en fase sólida de preparación de un compuesto que tiene la fórmula c[AA1-AA6]-AA7-ol, en la que AA1 es ácido propiónico, AA2 es preferiblemente D-Trp, AA3 es Ile, AA4 es preferiblemente AlloIle, AA5 es Asn, AA6 es hCy, y AA7 es preferiblemente N-Me-Orn-ol, o una sal o solvato farmacéuticamente aceptable del mismo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15188529 | 2015-10-06 | ||
| PCT/EP2016/073858 WO2017060339A1 (en) | 2015-10-06 | 2016-10-06 | New methods for making barusiban and its intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018004282A true MX2018004282A (es) | 2018-08-09 |
Family
ID=54288657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018004282A MX2018004282A (es) | 2015-10-06 | 2016-10-06 | Nuevos procedimientos de fabricacion de barusiban y sus intermedios. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20180282367A1 (es) |
| EP (1) | EP3359557A1 (es) |
| JP (1) | JP2018535946A (es) |
| KR (1) | KR20180059549A (es) |
| CN (1) | CN108290929A (es) |
| AU (1) | AU2016335061B2 (es) |
| CA (1) | CA3001057A1 (es) |
| MX (1) | MX2018004282A (es) |
| RU (1) | RU2726414C2 (es) |
| WO (1) | WO2017060339A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019000498A (es) | 2016-07-21 | 2019-09-16 | ObsEva SA | Regímenes de dosis de antagonista de oxitocina para promover la implantación embrionaria y prevenir abortos espontaneos. |
| CN110894212B (zh) * | 2018-08-24 | 2021-06-04 | 翰宇药业（武汉）有限公司 | 一种合成依替巴肽硫醚的方法 |
| WO2021043726A1 (en) | 2019-09-03 | 2021-03-11 | ObsEva S.A. | Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage |
| EP4103750A1 (en) | 2020-02-10 | 2022-12-21 | ObsEva S.A. | Biomarkers for oxytocin receptor antagonist therapy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE501678C2 (sv) * | 1993-07-13 | 1995-04-10 | Ferring Bv | Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid |
| SE9604341D0 (sv) | 1996-11-26 | 1996-11-26 | Ferring Bv | Hepta-peptide oxytocin analogue |
| DE60309847T2 (de) * | 2002-02-27 | 2007-10-18 | Ferring B.V. | Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga |
| TWI463990B (zh) * | 2009-09-21 | 2014-12-11 | Ferring Bv | 催產素受體促進劑 |
| CN102875650B (zh) * | 2012-09-26 | 2014-06-11 | 深圳翰宇药业股份有限公司 | 巴卢西班的制备方法 |
-
2016
- 2016-10-06 EP EP16778343.0A patent/EP3359557A1/en not_active Withdrawn
- 2016-10-06 CA CA3001057A patent/CA3001057A1/en not_active Abandoned
- 2016-10-06 AU AU2016335061A patent/AU2016335061B2/en not_active Expired - Fee Related
- 2016-10-06 JP JP2018517557A patent/JP2018535946A/ja active Pending
- 2016-10-06 WO PCT/EP2016/073858 patent/WO2017060339A1/en active Application Filing
- 2016-10-06 KR KR1020187012844A patent/KR20180059549A/ko unknown
- 2016-10-06 US US15/765,933 patent/US20180282367A1/en not_active Abandoned
- 2016-10-06 RU RU2018116568A patent/RU2726414C2/ru active
- 2016-10-06 MX MX2018004282A patent/MX2018004282A/es unknown
- 2016-10-06 CN CN201680058334.1A patent/CN108290929A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018535946A (ja) | 2018-12-06 |
| WO2017060339A1 (en) | 2017-04-13 |
| CN108290929A (zh) | 2018-07-17 |
| EP3359557A1 (en) | 2018-08-15 |
| RU2018116568A (ru) | 2019-11-07 |
| RU2018116568A3 (es) | 2020-01-27 |
| AU2016335061B2 (en) | 2021-02-25 |
| KR20180059549A (ko) | 2018-06-04 |
| US20180282367A1 (en) | 2018-10-04 |
| RU2726414C2 (ru) | 2020-07-14 |
| CA3001057A1 (en) | 2017-04-13 |
| AU2016335061A1 (en) | 2018-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018004282A (es) | Nuevos procedimientos de fabricacion de barusiban y sus intermedios. | |
| EA201790407A1 (ru) | Зонды для визуализации белка хантингтина | |
| TW201613866A (en) | Process for preparing fluorinated iminopyridine compounds | |
| MX2016016297A (es) | Procedimientos para la preparacion de compuestos antivirales. | |
| EA201890899A1 (ru) | Модуляторы фарнезоидного x-рецептора | |
| EA201892430A1 (ru) | Синтез индазолов | |
| IL286592B (en) | Amino acid compounds for the treatment of liver disease | |
| EA201692548A1 (ru) | Минеральные аминокислотные комплексы активных веществ | |
| EA201791896A1 (ru) | Дезацетокситубулизин н и его аналоги | |
| IL267632A (en) | Exon skipping by peptide and nucleic acid sequences | |
| EA201790983A1 (ru) | Синтез копанлисиба и его дигидрохлорида | |
| PH12017501641A1 (en) | Acetate salt of buprenorphine and methods for preparing buprenorphine | |
| EA201790432A1 (ru) | Зонды для визуализации белка хантингтина | |
| EA202090980A1 (ru) | Синтез антибактериальных аминогликозидных аналогов | |
| IL261986B (en) | An improved process for the preparation of butorphanol tartrate | |
| SG11202100944XA (en) | Catalyst mixture | |
| SV2019005838A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| MX2018011529A (es) | Procesos para la preparacion de acidos heteroaril carboxilicos. | |
| WO2016056023A3 (en) | Intermediates and processes to prepare micafungin | |
| EA201992360A1 (ru) | Кристаллические формы (s)-афоксоланера | |
| HRP20190286T1 (hr) | Postupci za pripremu spojeva, kao što su 3-arilbutanali, korisni u sintezi medetomidina | |
| EA201491913A1 (ru) | Синтез калебина-а и его биологически активных аналогов | |
| WO2015076666A3 (en) | Combination of ghrelin and kisspeptin analogs (gpr54 agonists) for growth of aquatic animals | |
| GB201918108D0 (en) | Improved aminopeptiadases for single molecule peptide sequencing | |
| EA201890799A1 (ru) | Производные азетидина для визуализации тау-белка |